Cited by 244Dementia and Cognitive Impairment ResearchDiabetes Treatment and ManagementDiabetes, Cardiovascular Risks, and Lipoproteins

Risk score for prediction of 10 year dementia risk in individuals with type 2 diabetes: A cohort study

Open access
Exalto, Lieza G, Biessels, Geert Jan, Karter, Andrew J, Huang, Elbert S, Katon, Wayne J, Minkoff, Jerome R, Whitmer, Rachel A·2013·The Lancet Diabetes & Endocrinology

Abstract

Background Although patients with type 2 diabetes are twice as likely to develop dementia as those without this disease, prediction of who has the highest future risk is difficult. We therefore created and validated a practical summary risk score that can be used to provide an estimate of the 10 year dementia risk for individuals with type 2 diabetes.Methods Using data from two longitudinal cohorts of patients with type 2 diabetes (aged ≥60 years) with 10 years of follow-up, we created (n=29,961) and validated (n=2413) the risk score. We built our prediction model by evaluating 45 candidate predictors using Cox proportional hazard models and developed a point system for the risk score based on the size of the predictor's β coefficient. Model prediction was tested by discrimination and calibration methods. Dementia risk per sum score was calculated with Kaplan-Meier estimates.Findings Microvascular disease, diabetic foot, cerebrovascular disease, cardiovascular disease, acute metabolic events, depression, age, and education were most strongly predictive of dementia and constituted the risk score (C statistic 0·736 for creation cohort and 0·746 for validation cohort). The dementia risk was 5·3% (95% CI 4·2-6·3) for the lowest score (-1) and 73·3% (64·8-81·8) for the highest (12-19) sum scores.Interpretation To the best of our knowledge, this is the first risk score for the prediction of 10 year dementia risk in patients with type 2 diabetes mellitus. The risk score can be used to increase vigilance for cognitive deterioration and for selection of high-risk patients for participation in clinical trials.Funding Kaiser Permanente Community Benefit, National Institute of Health, Utrecht University, ZonMw, and Fulbright.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/s2213-8587(13)70048-2

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Among diabetics, micro- and macrovascular complications increase the risk of cognitive decline further, suggesting vascular mechanisms including atherosclerosis are important.

    “Among diabetics, the presence of micro- and macrovascular complications increases the risk of cognitive decline even further, suggesting that vascular mechanisms, including atherosclerosis, are important players [7].”

    From Neuroprotective effect of SGLT2 inhibitors. (2021) · cites this paper as [7]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The citation lists haven’t been fetched yet

References 30 · Cited by 244

Authors
Exalto, L. G., Biessels, G. J., Karter, A. J., Huang, E. S., Katon, W. J., Minkoff, J. R., & Whitmer, R. A.
Affiliations
  • Kaiser Permanente (US)
  • University Medical Center Utrecht (NL)
  • University of Chicago (US)
  • University of Washington (US)
Corresponding author
Whitmer, Rachel A
Venue
The Lancet Diabetes & Endocrinology
Publisher
Elsevier BV
Published
2013-11
Volume
1
Issue
3
Pages
183-190
ISSN
2213-8587 (ISSN-L)
OpenAlex
W2054881009
Cited by
244
References
30
Citations by year
2026: 12 · 2025: 18 · 2024: 18 · 2023: 22 · 2022: 21 · 2021: 21 · 2020: 17 · 2019: 26 · 2018: 22 · 2017: 14 · 2016: 17 · 2015: 19 · 2014: 14 · 2013: 3
FWCI
12.51
Type
journal article
Language
en
Open access
Locations
  • The Lancet Diabetes & Endocrinology (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
  • Utrecht University Repository (Utrecht University) (submittedVersion)
  • eScholarship (California Digital Library) (submittedVersion)
Funders
  • Kaiser Permanente
  • University of Chicago
  • University of Washington
  • National Institute of Diabetes and Digestive and Kidney Diseases (R01DK081796, R01DK065664, P30DK092949, P30DK092924)
  • Eunice Kennedy Shriver National Institute of Child Health and Human Development (R01HD046113)
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
Keywords
dementia risk, type 2 diabetes, risk score, dementia prediction, microangiopathy, diabetic foot, cerebrovascular disease, cardiovascular disease, depression, cognitive decline, older adults, risk prediction model
MeSH terms
Age Factors, Cardiovascular Diseases, Cerebrovascular Disorders, Dementia, Depression, Diabetes Mellitus, Type 2, Educational Status, Humans, Risk Factors, Cohort Studies, Proportional Hazards Models, Diabetic Foot, Risk Assessment, Kaplan-Meier Estimate

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review